吸入一酸化窒素市場規模、シェア、成長分析：製品タイプ別、用途別、強さ別、製品別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

吸入一酸化窒素の世界市場規模は、2023年に12億米ドルと評価され、予測期間（2025-2032年）にCAGR 7.9％で成長し、2024年の12億9,000万米ドルから2032年には23億8,000万米ドルに成長する見通しです。

一酸化窒素は、多臓器の生存と血管の健康に不可欠な化学物質として機能し、重要な抗菌特性と心・脳血管の利点を示します。一酸化窒素は換気と灌流のマッチングを高め、動脈酸素化を促進するため、呼吸療法において貴重な存在となっています。アスリートやフィットネス愛好家は一般的に一酸化窒素を補給し、運動中の血流、酸素供給、栄養吸収の増加の恩恵を受けており、市場の需要を牽引しています。業界の主要企業は、特に製薬・ヘルスケア分野において、窒素や酸素のような必須ガスの輸送ネットワークの最適化に注力しています。吸入一酸化窒素市場は、ヘルスケアへの応用に対する意識の高まり、心血管疾患や呼吸器疾患の発生率の上昇、進行中の研究開発によって成長する見込みです。医療関係者が吸入一酸化窒素の治療効果を認識するにつれ、吸入一酸化窒素の需要は急増すると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

吸入一酸化窒素市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 小児
• 成人

吸入一酸化窒素市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 吸入一酸化窒素配信システム
• 消耗品
• 一酸化窒素ボンベ
• 配送アクセサリ
• その他

吸入一酸化窒素市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 新生児呼吸器治療
• 慢性閉塞性肺疾患（COPD）
• 急性呼吸窮迫症候群（ARDS）
• 結核治療
• マラリア治療
• その他

吸入一酸化窒素市場規模：強さ別& CAGR（2025-2032）

• 市場概要
• 100ppm
• 800ppm
• その他

吸入一酸化窒素市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 使い捨て
• システム

吸入一酸化窒素市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 外来センター
• クリニック

吸入一酸化窒素市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Mallinckrodt Pharmaceuticals（United States）
• Key Developments
• Air Liquide Healthcare（France）
• VERO Biotech（United States）
• Getinge AB（Sweden）
• Beyond Air, Inc.（United States）
• SLE Ltd.（United Kingdom）
• Bellerophon Therapeutics（United States）
• International Biomedical（United States）
• NIOX Group plc（United Kingdom）
• BOC Healthcare（United Kingdom）
• Merck KGaA（Germany）
• Nu-Med Plus Inc.（United States）
• Perma Pure LLC（United States）
• HALMA PLC（United Kingdom）
• Matheson Tri-Gas Inc.（United States）
• Circassia Pharmaceuticals（United Kingdom）
• International Biomedical（United States）

結論と推奨事項

Global Inhaled Nitric Oxide Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.38 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

Nitric oxide serves as a vital chemical for multiorgan survival and vascular health, showcasing significant antibacterial properties and cardio-cerebrovascular advantages. It enhances ventilation-perfusion matching and arterial oxygenation, making it invaluable in respiratory therapies. Athletes and fitness enthusiasts commonly supplement with nitric oxide, benefiting from increased blood flow, oxygen delivery, and nutrient absorption during exercise, driving market demand. Key industry players focus on optimizing transport networks for essential gases like nitrogen and oxygen, particularly within the pharmaceutical and healthcare sectors. The inhaled nitric oxide market is poised for growth, propelled by heightened awareness of its healthcare applications, rising rates of cardiovascular and respiratory conditions, and ongoing research developments. As medical professionals recognize its therapeutic benefits, demand for inhaled nitric oxide is expected to surge.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Market Segments Analysis

Global Inhaled Nitric Oxide Market is segmented by Type, Product Type, Application, Strength, Product, End-user and Region. Based on Type, the market is segmented into Pediatric and Adult. Based on Product Type, the market is segmented into Inhaled Nitric Oxide Delivery Systems, Consumables, Nitric Oxide Cylinders, Delivery Accessories and Others. Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment and Others. Based on Strength, the market is segmented into 100 ppm, 800 ppm and Others. Based on Product, the market is segmented into Disposables and System. Based on End-user, the market is segmented into Hospitals, Ambulatory Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is greatly influenced by the increasing incidence of respiratory diseases. As these conditions affect a larger segment of the population worldwide, the demand for inhaled nitric oxide as a therapeutic option is expected to rise correspondingly. Various environmental factors, including air pollution, tobacco smoke, and occupational hazards, contribute significantly to respiratory health issues, heightening the risk of developing respiratory conditions. Additionally, the aging population faces diminished immune responses and natural declines in lung function, making them more susceptible to these illnesses. Consequently, as the global population ages, the prevalence of respiratory disorders is likely to escalate.

Restraints in the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market faces several restraints due to stringent regulatory requirements that products must satisfy. The standardisation and approval processes for pharmaceutical products are both costly and time-consuming, which can hinder market growth and slow the introduction of new therapies. Additionally, pricing and reimbursement strategies present substantial regulatory hurdles in various healthcare systems. Companies must engage in complex negotiations with payers to ensure financial reimbursement for their products, all while successfully navigating the intricate landscape of health technology assessment. These factors collectively pose challenges to market accessibility and innovation within the industry.

Market Trends of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is witnessing a significant upward trend, primarily driven by the rising prevalence of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These conditions, exacerbated by factors like increased smoking and industrialization, pose serious health risks and impair quality of life, thus elevating the need for effective treatments. Inhaled nitric oxide has emerged as a promising therapeutic option for managing these ailments, improving pulmonary function and providing symptomatic relief. As awareness of its benefits spreads and patient populations grow, the market is expected to expand substantially in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Inhaled Nitric Oxide Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult

Global Inhaled Nitric Oxide Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhaled Nitric Oxide Delivery Systems
• Consumables
• Nitric Oxide Cylinders
• Delivery Accessories
• Others

Global Inhaled Nitric Oxide Market Size by Application & CAGR (2025-2032)

• Market Overview
• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Tuberculosis Treatment
• Malaria Treatment
• Others

Global Inhaled Nitric Oxide Market Size by Strength & CAGR (2025-2032)

• Market Overview
• 100 ppm
• 800 ppm
• Others

Global Inhaled Nitric Oxide Market Size by Product & CAGR (2025-2032)

• Market Overview
• Disposables
• System

Global Inhaled Nitric Oxide Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Centers
• Clinics

Global Inhaled Nitric Oxide Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Application, Strength, Product, End-user)
  • US
  • Canada
• Europe (Type, Product Type, Application, Strength, Product, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Application, Strength, Product, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Application, Strength, Product, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Application, Strength, Product, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Air Liquide Healthcare (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VERO Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beyond Air, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLE Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIOX Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nu-Med Plus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perma Pure LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HALMA PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matheson Tri-Gas Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circassia Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations